The global dermatoscope market accounted for USD 0.915 billion in 2023 and is expected to reach at USD 3.23 billion by 2034 with a CAGR of 12.15% during the forecast period 2024-2034. Rise in prevalence of skin cancer, heightened need for advanced diagnostic methods for long-term skin conditions, increasing awareness regarding the skin cancer, growing advancements in technology, particularly in dermatology, rising focus on improving both medical & aesthetic outcomes, surge in approval of novel devices, and increasing launch of cutting-edge dermatoscope devices are some of the key factors boosting the market growth.
Dermatoscopy, a technique where skin lesions are examined using a dermatoscope, is widely utilized by dermatologists. This tool helps distinguish between benign and malignant lesions, especially in detecting melanoma. Healthcare providers find dermatoscopy highly efficient and beneficial in diagnosing a range of skin conditions, surpassing traditional diagnostic approaches. For instance, in March 2024, FotoFinder Systems, a prominent provider of advanced skin imaging solutions worldwide, introduces skeen, an innovative wireless digital dermatoscope featuring cloud-based storage. This revolutionary device aims to revolutionize skin and hair examinations by incorporating state-of-the-art technology and artificial intelligence (AI).
By product, contact dermatoscopes was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the increase in the number of patients with skin conditions, rise in the elderly population, advancements in contact dermatoscope technology, and surge in product introductions. For instance, in June 2023, DeepC Diagnostics, a company specializing in skin cancer teledermatology and diagnostics, has obtained approval from the US Food and Drug Administration (FDA) for its digital dermatoscope, DermoSight. This clearance allows for the use of DermoSight in screening suspicious skin cancer lesions via teledermatology in the United States. Additionally, hybrid dermatoscopes is predicted to grow at the fastest CAGR during the forecast period. These innovative medical devices offer features of both contact and non-contact dermatoscopes. They also integrate both polarized and non-polarized imaging modes for imaging purposes.
By technology, LED was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the increasing approval of novel devices, by regulatory bodies. The adoption of this technology is rising because LEDs generate less heat during illumination, thus lowering the risk of accidental injuries or fatalities. For instance, in February 2022, Casio America Inc has revealed that it has obtained FDA clearance for its DZ100 DERMOCAMERA and DZ-S50 devices for skin observation. Additionally, ultraviolet is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend of introducing innovative technology in the realm of dermatoscopy.
By modality, handheld was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the ease of use of these products, lightweight and offer superior viewing experiences. They provide improved visualization, enabling dermatologists to better comprehend various conditions, while the increasing regulatory approval of new devices adds to their appeal. For instance, in January 2024, The FDA has granted approval for DermaSensor, the inaugural AI-driven tool for diagnosing skin cancer, such as melanoma, basal cell carcinoma, and squamous cell carcinoma, directly at the point of testing and without invasive procedures. Additionally, headband is predicted to grow at the fastest CAGR during the forecast period owing to the innovative technology incorporated in these devices involves dermatologists wearing them on their heads to illuminate lesions on a patient's skin.
By end-user, dermatology clinics was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the rising incidence of skin cancer & melanoma, increase in patients seeking treatment and care at dermatology clinics. These clinics are equipped with advanced medical equipment, enabling swift and accurate diagnoses, while collaborations among industry players are on the rise. For instance, in March 2023, Open Medical Ltd, a UK-based medical device manufacturer, and FotoFinder Systems GmbH, a Germany-based company specializing in skin imaging systems, have announced a partnership. They aim to leverage the technology from both companies to improve skin visualization through the utilization of advanced LED technology. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to the heightened risk of skin cancer, ready availability of specialized doctors in hospitals, facilitating convenient diagnosis & treatment. Individuals diagnosed with cancer are more inclined to seek advanced diagnosis and treatment in hospital settings.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of skin diseases, the presence of advanced healthcare infrastructure and rising approvals from regulatory authorities. For instance, in September 2022, A prominent medical equipment manufacturer, Sklip Inc, has disclosed that it obtained approval from an institutional review board based in an academic hospital to conduct clinical trials for the Sklip artificial intelligence (AI) skin cancer triage designed for patients in home settings. Prior to this, the Sklip AI had already secured clearance from the U.S. Food and Drug Administration (FDA). Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the occurrence of basal cell carcinoma, melanoma, actinic keratosis, squamous cell carcinoma, inflammatory dermatoses, & non-pigmented skin lesions, increased adoption of cutting-edge devices for skin cancer diagnosis and surge in the introduction of innovative devices. For instance, in June 2023, FotoFinder Systems GmbH, a globally renowned producer of medical imaging systems for dermatology, reveals the launch of two groundbreaking innovations: meesma, a novel portable imaging solution tailored for aesthetics, and the FotoFinder ATBM master 4th Generation - designed to enhance intelligence and efficiency in Total Body Dermoscopy, featuring its cutting-edge AI Assistant, AIMEE.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Dermatoscopy, a technique where skin lesions are examined using a dermatoscope, is widely utilized by dermatologists. This tool helps distinguish between benign and malignant lesions, especially in detecting melanoma. Healthcare providers find dermatoscopy highly efficient and beneficial in diagnosing a range of skin conditions, surpassing traditional diagnostic approaches. For instance, in March 2024, FotoFinder Systems, a prominent provider of advanced skin imaging solutions worldwide, introduces skeen, an innovative wireless digital dermatoscope featuring cloud-based storage. This revolutionary device aims to revolutionize skin and hair examinations by incorporating state-of-the-art technology and artificial intelligence (AI).
By product, contact dermatoscopes was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the increase in the number of patients with skin conditions, rise in the elderly population, advancements in contact dermatoscope technology, and surge in product introductions. For instance, in June 2023, DeepC Diagnostics, a company specializing in skin cancer teledermatology and diagnostics, has obtained approval from the US Food and Drug Administration (FDA) for its digital dermatoscope, DermoSight. This clearance allows for the use of DermoSight in screening suspicious skin cancer lesions via teledermatology in the United States. Additionally, hybrid dermatoscopes is predicted to grow at the fastest CAGR during the forecast period. These innovative medical devices offer features of both contact and non-contact dermatoscopes. They also integrate both polarized and non-polarized imaging modes for imaging purposes.
By technology, LED was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the increasing approval of novel devices, by regulatory bodies. The adoption of this technology is rising because LEDs generate less heat during illumination, thus lowering the risk of accidental injuries or fatalities. For instance, in February 2022, Casio America Inc has revealed that it has obtained FDA clearance for its DZ100 DERMOCAMERA and DZ-S50 devices for skin observation. Additionally, ultraviolet is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend of introducing innovative technology in the realm of dermatoscopy.
By modality, handheld was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the ease of use of these products, lightweight and offer superior viewing experiences. They provide improved visualization, enabling dermatologists to better comprehend various conditions, while the increasing regulatory approval of new devices adds to their appeal. For instance, in January 2024, The FDA has granted approval for DermaSensor, the inaugural AI-driven tool for diagnosing skin cancer, such as melanoma, basal cell carcinoma, and squamous cell carcinoma, directly at the point of testing and without invasive procedures. Additionally, headband is predicted to grow at the fastest CAGR during the forecast period owing to the innovative technology incorporated in these devices involves dermatologists wearing them on their heads to illuminate lesions on a patient's skin.
By end-user, dermatology clinics was the highest revenue-grossing segment in the global dermatoscope market in 2023 owing to the rising incidence of skin cancer & melanoma, increase in patients seeking treatment and care at dermatology clinics. These clinics are equipped with advanced medical equipment, enabling swift and accurate diagnoses, while collaborations among industry players are on the rise. For instance, in March 2023, Open Medical Ltd, a UK-based medical device manufacturer, and FotoFinder Systems GmbH, a Germany-based company specializing in skin imaging systems, have announced a partnership. They aim to leverage the technology from both companies to improve skin visualization through the utilization of advanced LED technology. Additionally, hospitals is predicted to grow at the fastest CAGR during the forecast period owing to the heightened risk of skin cancer, ready availability of specialized doctors in hospitals, facilitating convenient diagnosis & treatment. Individuals diagnosed with cancer are more inclined to seek advanced diagnosis and treatment in hospital settings.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of skin diseases, the presence of advanced healthcare infrastructure and rising approvals from regulatory authorities. For instance, in September 2022, A prominent medical equipment manufacturer, Sklip Inc, has disclosed that it obtained approval from an institutional review board based in an academic hospital to conduct clinical trials for the Sklip artificial intelligence (AI) skin cancer triage designed for patients in home settings. Prior to this, the Sklip AI had already secured clearance from the U.S. Food and Drug Administration (FDA). Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the occurrence of basal cell carcinoma, melanoma, actinic keratosis, squamous cell carcinoma, inflammatory dermatoses, & non-pigmented skin lesions, increased adoption of cutting-edge devices for skin cancer diagnosis and surge in the introduction of innovative devices. For instance, in June 2023, FotoFinder Systems GmbH, a globally renowned producer of medical imaging systems for dermatology, reveals the launch of two groundbreaking innovations: meesma, a novel portable imaging solution tailored for aesthetics, and the FotoFinder ATBM master 4th Generation - designed to enhance intelligence and efficiency in Total Body Dermoscopy, featuring its cutting-edge AI Assistant, AIMEE.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Technology, Modality, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Dermatoscope Market Report 2023 - 2034
Dermatoscope Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Hybrid Dermatoscope
- Contact Dermatoscope
- Noncontact Dermatoscope
Dermatoscope Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Halogen
- LED
- Ultraviolet
- Xenon
Dermatoscope Market Analysis & Forecast by Modality 2023 - 2034 (Revenue USD Bn)
- Trolley Mounted
- Headband
- Handheld
Dermatoscope Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Dermatology Clinics
Dermatoscope Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Dermatoscope Market: Product Estimates & Trend Analysis
8. Dermatoscope Market: Technology Estimates & Trend Analysis
9. Dermatoscope Market: Modality Estimates & Trend Analysis
10. Dermatoscope Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Dermatoscope Market
13. Europe Global Dermatoscope Market
14. Asia Pacific Global Dermatoscope Market
15. Latin America Global Dermatoscope Market
16. MEA Global Dermatoscope Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- HEINE Optotechnik GmbH & Co. KG
- Caliber Imaging & Diagnostics Inc.
- ILLUCO Corporation Ltd.
- Optilia Instruments AB
- Canfield Scientific Inc.
- Bio-Therapeutic Inc.
- FotoFinder Systems
- Firefly Global
- Welch Allyn
- 3Gen
